000 | 02929 a2200841 4500 | ||
---|---|---|---|
005 | 20250516073312.0 | ||
264 | 0 | _c20120325 | |
008 | 201203s 0 0 eng d | ||
022 | _a1460-2105 | ||
024 | 7 |
_a10.1093/jnci/djr540 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWang-Johanning, Feng | |
245 | 0 | 0 |
_aImmunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors. _h[electronic resource] |
260 |
_bJournal of the National Cancer Institute _cFeb 2012 |
||
300 |
_a189-210 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Anti-Idiotypic _xpharmacology |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aBromodeoxyuridine _xmetabolism |
650 | 0 | 4 |
_aCarcinoma, Ductal, Breast _xdrug therapy |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aEndogenous Retroviruses |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFeasibility Studies |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 | _aFluorescent Antibody Technique |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aGene Expression Regulation, Viral |
650 | 0 | 4 |
_aGene Products, env _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunoblotting |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aImmunotherapy _xmethods |
650 | 0 | 4 | _aIn Situ Nick-End Labeling |
650 | 0 | 4 |
_aKi-67 Antigen _xanalysis |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 | _aNeoplasm Grading |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aPilot Projects |
650 | 0 | 4 | _aProtein Array Analysis |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 |
_aRetroviridae Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 | _aTransplantation, Heterologous |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
650 | 0 | 4 | _aUp-Regulation |
700 | 1 | _aRycaj, Kiera | |
700 | 1 | _aPlummer, Joshua B | |
700 | 1 | _aLi, Ming | |
700 | 1 | _aYin, Bingnan | |
700 | 1 | _aFrerich, Katherine | |
700 | 1 | _aGarza, Jeremy G | |
700 | 1 | _aShen, Jianjun | |
700 | 1 | _aLin, Kevin | |
700 | 1 | _aYan, Peisha | |
700 | 1 | _aGlynn, Sharon A | |
700 | 1 | _aDorsey, Tiffany H | |
700 | 1 | _aHunt, Kelly K | |
700 | 1 | _aAmbs, Stefan | |
700 | 1 | _aJohanning, Gary L | |
773 | 0 |
_tJournal of the National Cancer Institute _gvol. 104 _gno. 3 _gp. 189-210 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/jnci/djr540 _zAvailable from publisher's website |
999 |
_c21462821 _d21462821 |